AI imaging for esophageal cancer treatment decisions
Part of Cancer, Digestive system clinical trials.
This trial is testing an AI system that uses MRI scans and tissue samples to help doctors choose the best treatment for esophageal cancer. It's only for people who haven't had any cancer treatment yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have been diagnosed with esophageal cancer through a biopsy.
- You cannot have received any prior cancer treatment (like chemotherapy, radiation, or surgery).
- You must be able to safely have an MRI (no metal implants, pacemaker, or severe claustrophobia).
- You must be willing to follow the study plan and let your images be used for AI analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
This trial uses CT and MRI scans before and after chemotherapy or radiation to see how well the treatment worked in esophageal cancer. The goal is to match scan results with what doctors find after surgery.
This study uses artificial intelligence to look at CT scans you've already had (without dye) to try and find signs of several types of cancer early. It may help find cancer sooner when it's easier to treat.
This trial uses artificial intelligence to create a digital twin of your cancer and simulate how it might respond to different treatments. The goal is to find the best treatment plan for you before you start therapy.
This trial uses advanced imaging tests (spectral CT, multimodal MRI, and FAPI PET-CT) before surgery to find if esophageal cancer has spread to lymph nodes. The goal is to improve how doctors predict and diagnose lymph node metastasis using these scans, along with pathology and AI analysis.
This trial uses artificial intelligence to analyze CT scans and predict how well esophageal cancer responds to chemotherapy combined with immunotherapy before surgery. The goal is to help doctors personalize treatment for better outcomes.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.